SnapSlide Introduces First Child-Resistant, Single-Handed Opening for Prescription Vials

SnapSlide™, a packaging innovations company dedicated to making it easier for consumers to access, use, and store pharmaceutical products, has introduced a line of no-torque, child-resistant caps that easily integrate with current prescription amber vials. The market's first adaptive packaging solution, SnapSlide's ergonomic design features a patented, sliding, two-step opening procedure that allows for single-handed opening and closing while maintaining child resistance.

Engineered specifically to aid millions of consumers with physical disabilities and limitations, the user-friendly cap closure technology uses a slide-to-open/close functionality that requires less force and dexterity to operate than the current push-and-turn technology.

A woman with one hand smiles as she easily operates the SnapSlide

The cap itself stays firmly affixed to the vials, adding an additional dimension of safety and convenience while allowing for easy, metered dosing. The closure system also provides definitive security feedback, by producing a 57-decibel "snap" upon closing—an auditory cue helping consumers recognize still-open medicine bottles.

Significantly Improved Drug Accessibility for 70 Million Americans

SnapSlide's simple yet effective technology represents a potentially life-changing innovation for the over 70 million Americans who have some form of dexterity issue such as arthritis, fibromyalgia, multiple sclerosis and Parkinson's disease.

Of these, an estimated 12 million are temporarily or permanently unable to use one of their arms or hands. These include amputees, stroke/paralysis patients, and many faced with congenital birth defects, for whom conventional pharmaceutical closures are virtually impossible to open, dose and close with one arm.

Close-up of the SnapSlide lid with two images of a person’s singe hand easily sliding the cap open.

Additionally, SnapSlide has shown itself to be substantially more popular regardless of dexterity issues. In focus groups, nearly 90% of consumers preferred SnapSlide to conventional amber vial closures. Two-thirds reported they would be more loyal to brands adopting SnapSlide—and likely to switch to a competing brand if theirs did not incorporate the solution.

SnapSlide's solution is also available for oral solid dose over the counter (OTC) applications, and the cap's simple design makes it easily adaptable for a wide variety of common containers, including plastic and glass bottles that require child resistance.

Notably, the cost-effective SnapSlide also promotes sustainability, and does not require significant downstream production process adjustments: SnapSlide's unique design is more than 20% lighter than the average conventional amber vial closure and decreases overall plastic usage while maintaining similar costs to current cap closure solutions—all with limited conversion requirements.

Image displays two traditional child-resistant Rx caps on either side of the SnapSlide child-resistant Rx cap, which is 27% lighter.

"The SnapSlide prescription vial caps have the potential to be better for all and life-changing for many," said Rocky Batzel, CEO and Founder of SnapSlide. "For consumers with physical limitations, the cap provides convenience, accessibility, safety and independence. For retail chains, it has the potential to transform child-resistant packaging from an undifferentiated commodity into a competitive advantage."

SnapSlide Makes its Abilities Expo Debut

Meet the team from SnapSlide, and try the life-changing solution in person, in booth #221 at the 2024 Abilities Expo New York Metro, May 3-5.

Or learn more at and connect with SnapSlide on Facebook, LinkedIn, YouTube and Instagram.

SnapSlide Pharma Explainer from SnapSlide on Vimeo.

Pre-Register for Abilities Expo Today...It's Free!

Sign up for the Abilities Buzz

Stay in the know on disability news and info.